e-learning
resources
London 2016
Tuesday, 06.09.2016
How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma
Masaru Suzuki (Sapporo, Japan), Masaru Suzuki, Satoshi Konno, Hironi Makita, Kaoruko Shimizu, Hiroki Kimura, Hirokazu Kimura, Masaharu Nishimura
Source:
International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Session:
How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Session type:
Poster Discussion
Number:
3410
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Masaru Suzuki (Sapporo, Japan), Masaru Suzuki, Satoshi Konno, Hironi Makita, Kaoruko Shimizu, Hiroki Kimura, Hirokazu Kimura, Masaharu Nishimura. Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma. Eur Respir J 2016; 48: Suppl. 60, 3410
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
RNA-Seq transcriptome profiling of genes regulated by vitamin D in an asthma model
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Genetic variation in human RHS7 of the T
H
2 locus control region influences DNA methylation and is associated with IgE
Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology
Year: 2014
Re-sequencing of
IL33
and
IL1RL1
in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
Polymorphisms in all three
ORMDL
genes are associated with asthma and their mRNA expression is increased in asthmatics
Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology
Year: 2014
meQTL analysis of asthma GWAS loci and DNA methylation
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Re-sequencing of
PLAUR
in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Gene set variation analysis of mRNA expression in bronchial biopsies from the U-BIOPRED asthma study
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Transcriptome analysis of controlled and problematic severe childhood asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Microarray analysis of long non-coding RNAs in COPD
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Expression of genes associated with neurogenic inflammation in pediatric asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Variants of apelin gene and COPD
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Metabolomics profiling identifies female-selective upregulation of oxidative stress in individuals with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
LATE-BREAKING ABSTRACT: Transcriptomic fingerprinting in severe adult-onset asthma shows type2-high and inflammatory-cell gene signatures in the U-BIOPRED cohort
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
FKBP5 a candidate for corticosteroid insensitivity in COPD
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
Telomere attrition in circulating white blood cells in COPD relates to lung function and outcomes
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
The asthma-COPD overlap syndrome: Transcription factors GATA3 and STAT6 as possible markers
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept